Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Operating Leases (2019 - 2025)

Historic Operating Leases for Inspire Medical Systems (INSP) over the last 7 years, with Q4 2025 value amounting to $32.2 million.

  • Inspire Medical Systems' Operating Leases rose 113.86% to $32.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $32.2 million, marking a year-over-year increase of 113.86%. This contributed to the annual value of $32.2 million for FY2025, which is 113.86% up from last year.
  • Inspire Medical Systems' Operating Leases amounted to $32.2 million in Q4 2025, which was up 113.86% from $32.6 million recorded in Q3 2025.
  • Inspire Medical Systems' 5-year Operating Leases high stood at $33.5 million for Q1 2025, and its period low was $6.0 million during Q1 2021.
  • For the 5-year period, Inspire Medical Systems' Operating Leases averaged around $19.2 million, with its median value being $23.9 million (2023).
  • Its Operating Leases has fluctuated over the past 5 years, first plummeted by 730.54% in 2023, then soared by 18648.27% in 2024.
  • Over the past 5 years, Inspire Medical Systems' Operating Leases (Quarter) stood at $9.1 million in 2021, then dropped by 2.59% to $8.9 million in 2022, then skyrocketed by 180.05% to $24.8 million in 2023, then grew by 27.96% to $31.8 million in 2024, then rose by 1.14% to $32.2 million in 2025.
  • Its Operating Leases was $32.2 million in Q4 2025, compared to $32.6 million in Q3 2025 and $33.1 million in Q2 2025.